All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Ask about triggers (e.g., pets) and if symptoms are intermittent or all year round (perennial).
Urgent referral via the suspected Head and Neck Cancer pathway should be considered if there are:
or
No investigations required prior to referral.
1. For seasonal allergic rhinitis, treatment should be initiated at least 2 weeks before the anticipated start of the pollen season.
2. Allergen avoidance where possible (e.g., house dust mite reduction measures or pet avoidance).
3. Mild symptoms should be treated with oral non-sedating antihistamines at doses up to twice BNF maximum dosing
4. Moderate-severe symptoms should be treated with intranasal corticosteroid (in addition to non-sedating antihistamines)
5. Consistent daily use of intranasal use is vital, given maximal effect may not be apparent for at least two weeks.
6. Training in appropriate nasal spray technique essential. Guidance can be found here.
7. Systemic corticosteroids (in addition to intranasal corticosteroid and non-sedating antihistamines) at doses of 15-20mg for a maximum of 5 days as a one-off course can be used for severe symptoms uncontrolled on conventional therapy e.g., to control symptoms during important periods (e.g. exams or other major events).
8. Topical anti-inflammatory eye drops are useful to manage allergic conjunctivitis
Consider a concomitant diagnosis of asthma and manage according to guidelines.
Avoid sedating antihistamines, depot corticosteroids, and chronic use of decongestants.
Treatment failure should prompt a review of the diagnosis, compliance with therapy (regular therapy is more effective than “as required” treatment), and intranasal corticosteroid technique.
Experience from Peninsula Immunology and Allergy Service suggests that 70% of patients referred with severe symptoms achieve satisfactory symptom control using non-sedating antihistamines and regular intranasal corticosteroids alone.
For more information see:
South and West Devon Formulary: 12.2.1 Drugs used in nasal allergy, 12.2.2 Topical nasal decongestants
BSACI - Rhinitis management guidelines
Onlinelibrary.wiley - guidelines for the management of allergic and non-allergic rhinitis
The information essential for clinical triage is outlined on the referral form.
For efficiency and to minimise returned referrals, use of the referral form is recommended.
Referrals not on the referral form will be accepted as long as all the essential information is included in a referral letter.
Onlinelibrary.wiley - guidelines for the management of allergic and non-allergic rhinitis
This guideline has been signed off on behalf of NHS Devon.
Publication date: March 2016
Updated: December 24